This streamlined approach not only accelerates the drug discovery pipeline but also improves the overall success rate of identifying viable drug targets. The AI-Powered Target Identification Service ...

There is no denying that artificial intelligence (AI) has captured ... used in the Schrödinger Drug Discovery Group for identifying hits for a wide range of target product profiles (TPP), with ...

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

In this article, we present a framework designed to evaluate the progress and impact of AI tools across various use cases in drug discovery ... 20 drugs with disease-target associations identified ...

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Among the investors is GlaxoSmithKline, which is teaming up with the biotech startup in a multi-target ... rare disease drug discovery. The founders of Vesalius Therapeutics say AI and machine ...

A leading UK AI in drug discovery event that brings together the highest number of big pharma speakers for focused discussions and networking. this year’s event will feature topics including ...